This study examined the effects of current asthma medications such as corticosteroids and β2 agonists and potential novel treatments such as NF-κB inhibitors, as well as their combination in the treatment of RV-induced inflammation and RV replication in airway fibroblasts. Here, NFKB1 is linked to asthma.